Shorter blood thinner after hip replacement: a recovery study
Part of Heart & circulation, Lungs & breathing clinical trials.
This study tests a shorter course of blood thinner medication (rivaroxaban) after hip replacement surgery, following an enhanced recovery plan. It aims to see if a shorter treatment can safely prevent blood clots and help you recover faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You are scheduled to have a planned first-time hip replacement surgery.
- You are able to walk and get up from a chair quickly (Timed Up and Go test under 20 seconds).
- You are not severely overweight (BMI under 40).
- You do not have serious kidney or liver disease, active cancer, or a history of blood clots.
- You are not already taking long-term blood thinners (except low-dose aspirin or clopidogrel).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injection called SRSD107 to see if it prevents blood clots after knee replacement surgery, compared to a standard blood thinner (enoxaparin). It might be an option if you are having a planned knee replacement and are otherwise healthy.
This study compares two types of blood thinners to prevent blood clots after knee replacement surgery. It will help find which one works better and is safer for patients.
This trial compares a personalized approach to preventing blood clots after hip or knee replacement surgery with the standard one-size-fits-all method. The goal is to see if tailoring prevention to each patient works better and is safer.
This study compares two ways to lower the risk of blood clots in people who had hip surgery and also had a slight heart injury. You will receive either a standard blood thinner (rivaroxaban) plus aspirin, or just aspirin alone, to see which works better without extra risk.
This trial compares two medicines to prevent blood clots after heart valve surgery. If you've had a tissue valve replaced or repaired, this study will see if a newer blood thinner (rivaroxaban) is safer and works better than the standard treatment.
This trial compares a new blood thinner called REGN7508 to two standard blood thinners (apixaban and enoxaparin) to prevent blood clots after total knee replacement surgery. The goal is to see which is safer and more effective.
Hear when a new Hip Arthroplasty, Total trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.